Martin Fassnacht

Endocrinology — University Hospital Würzburg, Germany

LeadR Profile

Martin Fassnacht University Hospital Würzburg Germany
2 670 ScienceLeadR Reputation 2670
Network Map

Endocrinology

Subspecialties: Oncology - Pharmacy - Pediatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026

Source: PubMed

University of Würzburg

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Atrial Natriuretic Peptide Regulates Zona Glomerulosa Growth and Aldosterone Release.
cells, hypertension, zona glomerulosa, aldosterone, growth, cytochrome p-450 cyp11b2, homeostasis, heart, communication, hyperaldosteronism, diet, herpes zoster, natriuretic peptides, atrial natriuretic factor, hemodynamics
Hypertension20260
Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial.
neoplasms, adrenocortical carcinoma, mitotane, prognosis
Cancers (Basel)20260
Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial.
diabetes mellitus, hypertension, quality of life, comorbidity, conservative treatment, dyslipidemias, hormones, adrenalectomy, body weight, obesity, therapeutics, overweight, hydrocortisone, endocrine system diseases
Eur J Endocrinol20260
Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing's syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients.
algorithms, hormones, machine learning, learning, adrenocorticotropic hormone, endocrine system diseases, cushing syndrome, sensitivity and specificity
Eur J Endocrinol20260
PYY 3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD.
genes, respiration, mitochondria, therapeutics, semaglutide
Am J Physiol Endocrinol Metab20260

Clinical Studies 30

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7 Study Director: 1

By phase:

N/A 16
Phase 3 8
Phase 2 4
Phase 1 1
Phase 4 1

By status:

Completed 17
Recruiting 7
Active not recruiting 4
Terminated 1
Unknown 1

By type:

Interventional 17
Observational 13

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 7
multicentric5to9 4
multicentricup10 10

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A randomized placebo controlled trial to evaluate the safety and efficacy of Debio 4126 in patients with acromegaly previously treated with somatostatin analogs
2024-516616-24-00 — somatostatin, safety, acromegaly, octreotide
Phase 3Recruiting2025
Belzutifan MK 6482 for the Treatment of Advanced Pheochromocytoma Paraganglioma (PPGL) Pancreatic Neuroendocrine Tumor (pNET) Von Hippel Lindau (VHL) Disease Associated Tumors Advanced Gastrointestinal Stromal Tumor (wt GIST) or Solid Tumors With HIF 2 Related Genetic Alterations (MK 6482 015)
NCT04924075 — cells, paraganglioma, islets of langerhans, safety, gastrointestinal stromal tumors, von hippel-lindau disease, pheochromocytoma, neoplasms, adenoma, islet cell, response evaluation criteria in solid tumors, neuroendocrine tumors, adenoma, therapeutics, neuroectodermal tumors, primitive
Phase 2Recruiting2021

LeadR Networks

Main global connection map